<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0002659"><a href="http://purl.obolibrary.org/obo/MONDO_0002659">MONDO:0002659</a></h3>
<p><strong>Label:</strong> uveal cancer</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0006486">MONDO:0006486</a> (uveal melanoma),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_606661">OMIM:606661</a>, <a href="http://purl.obolibrary.org/obo/OMIM_606660">OMIM:606660</a>, <a href="http://www.orpha.net/ORDO/Orphanet_39044">Orphanet:39044</a>, <a href="http://purl.obolibrary.org/obo/OMIM_155720">OMIM:155720</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0012055">HP:0012055</a> (Ciliary body melanoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012054">HP:0012054</a> (Choroidal melanoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011524">HP:0011524</a> (Iris melanoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012055">HP:0012055</a> (Ciliary body melanoma) and <a href="http://purl.obolibrary.org/obo/HP_0200026">HP:0200026</a> (Ocular pain) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012055">HP:0012055</a> (Ciliary body melanoma) and <a href="http://purl.obolibrary.org/obo/HP_0100533">HP:0100533</a> (Inflammatory abnormality of the eye) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012055">HP:0012055</a> (Ciliary body melanoma) and <a href="http://purl.obolibrary.org/obo/HP_0030800">HP:0030800</a> (Abnormal visual accommodation) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012055">HP:0012055</a> (Ciliary body melanoma) and <a href="http://purl.obolibrary.org/obo/HP_0030786">HP:0030786</a> (Photopsia) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012055">HP:0012055</a> (Ciliary body melanoma) and <a href="http://purl.obolibrary.org/obo/HP_0025142">HP:0025142</a> (Constitutional symptom) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012055">HP:0012055</a> (Ciliary body melanoma) and <a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012055">HP:0012055</a> (Ciliary body melanoma) and <a href="http://purl.obolibrary.org/obo/HP_0012647">HP:0012647</a> (Abnormal inflammatory response) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012055">HP:0012055</a> (Ciliary body melanoma) and <a href="http://purl.obolibrary.org/obo/HP_0012632">HP:0012632</a> (Abnormal intraocular pressure) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012055">HP:0012055</a> (Ciliary body melanoma) and <a href="http://purl.obolibrary.org/obo/HP_0012531">HP:0012531</a> (Pain) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012055">HP:0012055</a> (Ciliary body melanoma) and <a href="http://purl.obolibrary.org/obo/HP_0012508">HP:0012508</a> (Metamorphopsia) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012055">HP:0012055</a> (Ciliary body melanoma) and <a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012054">HP:0012054</a> (Choroidal melanoma) and <a href="http://purl.obolibrary.org/obo/HP_0200026">HP:0200026</a> (Ocular pain) 62.50%</li>
</ul>
</body>
</html>
